[Federal Register: January 22, 2002 (Volume 67, Number 14)]
[Notices]               
[Page 2890]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22ja02-81]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Workshop on Strengthening the Supply of Routinely Recommended 
Vaccines in the United States

    The National Vaccine Advisory Committee (NVAC), of the Centers for 
Disease Control and Prevention (CDC), announces the following meeting.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    Name: Workshop on Strengthening the Supply of Routinely Recommended 
Vaccines in the United States.
    Times and Dates: 8:30 a.m.--5 p.m., February 11, 2002. 8:30 a.m.--4 
p.m., February 12, 2002.
    Place: Omni Shoreham Hotel, 2500 Calvert Street, Washington, DC, 
Phone: 1-888-511-5743.
    Status: Open to the public, limited only by the space available. 
The meeting rooms will accommodate approximately 200 people.
    Purpose: The objectives of the Workshop are to define and describe 
the scope of the problem with vaccine supply in the United States; to 
identify and discuss possible contributing causes of and potential 
strategies to address the vaccine supply problem; and, to develop a 
limited number of pragmatic strategy options to address the vaccine 
supply issues in the United States.
    Matters to be Discussed: Agenda items will include presentations 
and discussion including: an overview of the problems associated with 
vaccine supply; financial incentives for research, development, and 
production; review of the regulatory process; government-owned 
contractor-operated vaccine production facilities; vaccine stockpiles; 
liability protections; tailoring strategies to specific shortages; and, 
perspectives of constituencies.
    Agenda items are subject to change as priorities dictate.
    Contact Persons for More Information: Stephen Sepe and Jeanne 
Santoli, CDC, 1600 Clifton Road, NE, Atlanta, Georgia 30333, telephone 
770-488-2040 (Sepe) and 404/639-8802 (Santoli). You may also visit the 
NVPO web site for additional information: www.cdc.gov/od/nvpo/calendar.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: January 11, 2002.
Joseph E. Salter,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-1221 Filed 1-18-02; 8:45 am]
BILLING CODE 4163-18-P